xenobiotic metabolizing gene variants and renal cell cancer: a multicenter study
Clicks: 297
ID: 229209
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
297 views
45 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #92 of 207 articles by views in international journal of heat and technology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 207 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Background:The countries of Central and Eastern Europe have among the highest worldwide rates of renal cell cancer. Few studies have examined whether genetic variation in xenobiotic metabolic pathway genes may modify risk for this cancer. Methods:The Central and Eastern Europe Renal Cell Cancer (RCC) study was a hospital-based case-control study conducted between 1998 and 2003 across seven centers in Central and Eastern Europe. Detailed data were collected from 874 cases and 2053 controls on demographics, work history and occupational exposure to chemical agents. Genes (cytochrome P-450 family, N-acetyltransferases, NAD(P)H:quinone oxidoreductase I (NQO1), microsomal epoxide hydrolase (mEH), catechol-O-methyltransferase (COMT), uridine diphosphate-glucuronosyltransferase (UGT)) were selected for the present analysis based on their putative role in xenobiotic metabolism. Haplotypes were calculated using fastPhase. Odds ratios (OR) and 95% confidence intervals (CI) were estimated by unconditional logistic regression adjusted for country of residence, age, and sex. Results:We observed an increased risk of renal cell cancer (RCC) with three SNPs. After adjustment for multiple comparisons no associations remained significant. In haplotype analyses, the NAT1*14A phenotype was associated with increased risk of RCC (OR=1.71, 95% CI 1.02, 2.87) in comparison to all other phenotypes, a finding that should be taken with caution. NAT2 slow acetylation was not associated with disease. Conclusion:We observed no association between this pathway and renal cell cancer.
| Reference Key |
heck2012frontiersxenobiotic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Julia E. Heck;Julia E. Heck;Lee eMoore;Yuan-Chin Amy eLee;James eMcKay;Rayjean eHung;Sara eKarami;Valérie eGaborieau;Neonila eSzeszenia-Dabrowska;David eZaridze;Anush eMukeriya;Dana eMates;Lenka eForetova;Vladimir eJanout;Helena eKollárová;Vladimir eBencko;Nathaniel eRothman;Paul eBrennan;Wong-Ho eChow;Paolo eBoffetta |
| Journal | international journal of heat and technology |
| Year | 2012 |
| DOI |
10.3389/fonc.2012.00016
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.